Closed · W81XWH-15-TSCRP-PCTA · CFDA 12.420 · Discretionary

DoD Tuberous Sclerosis Complex Pilot Clinical Trial Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
July 27, 2015
Close date
2
Expected awards

The verdict

DoD Tuberous Sclerosis Complex Pilot Clinical Trial Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.

Varies
award range
Closed
application status
2
expected awards
12.420
CFDA program

Archived opportunity record

DoD Tuberous Sclerosis Complex Pilot Clinical… is closed (last close July 27, 2015). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed July 27, 2015

Posted May 6 Closes Jul 27

Est. Total Funding

$960,000

Expected Awards

2

Instrument

Grant

Description

The PCTA mechanism supports exploratory studies involving limited human exposure that produce diagnostic or therapeutic information, safety, and tolerability studies and studies to determine the mechanism of action. These studies should be aimed at obtaining preliminary data leading to the development of interventions, as well as clinical biomarkers, with the potential to improve TSC outcomes. Preclinical studies will not be supported by this mechanism. Examples of acceptable studies include but are not limited to the following: • Identification of an appropriate population for the proposed study. • Identification of the dosage, duration, and/or delivery strategy of an intervention. • Evaluation of the feasibility of the intervention in TSC. • Development of clinical biomarkers or outcome measures for future clinical trials. • Evaluation of efficacy and safety. If the clinical trial involves the use of a drug that has not been approved by the U.S. Food and Drug Administration (FDA) for the proposed investigational use, then an Investigational New Drug (IND) application to the FDA that meets all requirements under the Code of Federal Regulations, Title 21, Part 312 (21 CFR 312) must be submitted to the FDA prior to the application submission deadline. If the investigational product is a device, evidence that an Investigational Device Exemption (IDE) application that meets all requirements under 21 CFR 812 has been submitted to the FDA prior to the application submission deadline, or that the device is exempt from an IDE, is required. Documentation of approval or exemption of the IND or IDE prior to programmatic review must be obtained and submitted to the CDMRP Help Desk (help@eBRAP.org), otherwise the Government reserves the right to withdraw the application

Catch-all / unrestricted eligibility mark · W81XWH-15-TSCRP-PCTA

Grants.gov marks DoD Tuberous Sclerosis Complex Pilot Clinical… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDMRP Help Desk Phone: 301-682-5507

What to do next

DoD Tuberous Sclerosis Complex Pilot Clinical… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants